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We report the 2.6 A˚ X-ray crystal structure of
a 190 kDa homodimeric fragment from module
3 of the 6-deoxyerthronolide B synthase cova-
lently bound to the inhibitor cerulenin. The
structure shows two well-organized interdo-
main linker regions in addition to the full-length
ketosynthase (KS) and acyltransferase (AT) do-
mains. Analysis of the substrate-binding site of
the KS domain suggests that a loop region at
the homodimer interface influences KS sub-
strate specificity. We also describe a model
for the interaction of the catalytic domains
with the acyl carrier protein (ACP) domain. The
ACP is proposed to dock within a deep cleft be-
tween the KS and AT domains, with interactions
that span both the KS homodimer and AT do-
main. In conjunction with other recent data,
our results provide atomic resolution pictures
of several catalytically relevant protein interac-
tions in this remarkable family of modularmega-
synthases.
INTRODUCTION
Polyketide synthases (PKSs) comprise a large family of
enzymes that catalyze the biosynthesis of structurally di-
verse and pharmacologically important natural products
[1]. They assemble polyketide chains through repeated
condensations between methylmalonyl or malonyl thio-
ester building blocks and the growing polyketide acyl thio-
esters. Analogous to vertebrate fatty acid synthases,
modular PKSs are large multienzyme assemblies that cat-
alyze polyketide biosynthesis by an assembly line of active
sites [2, 3]. In a typical PKS module, there are minimally
three domains: a catalytic ketosynthase (KS) and acyl-
transferase (AT) domain, and an acyl carrier protein
(ACP). The AT domain transfers an extender unit from
the corresponding malonyl- or methylmalonyl-CoA sub-
strate to the phosphopantetheine arm of the ACP. UponChemistry & Biology 14, 93receiving the growing polyketide chain from the appropri-
ate upstreammodule, the KS domain catalyzes decarbox-
ylative condensation between the resultant acyl-KS inter-
mediate and the respective malonyl- or methylmalonyl
extender unit to form a b-ketoacyl-ACP. The core catalytic
domains of a PKSmodule are flanked by catalytically inac-
tive 20–300 amino acid linker regions whose structure and
function are only beginning to be understood [4–6].
6-Deoxyerthronolide B synthase (DEBS), which pro-
duces the macrocyclic core of the antibiotic erythromycin,
is comprised of three homodimeric polypeptides subunits,
each of which consists of more than 3000 amino acids
(Figure 1). Each DEBS polypeptide ismade up of two poly-
ketide chain-elongation modules, with each module in-
cluding all of the required catalytic domains responsible
for one round of polyketide chain extension and b-keto
group modification. As the prototypical modular PKS,
DEBS has been intensively investigated over the past
two decades [7]. The modular nature of DEBS, together
with the medicinal significance of its product, has also
made it an attractive target for the production of novel poly-
ketides by combinatorial biosynthesis [8, 9]. While some
notable success in engineering DEBS to produce novel
macrolides has been achieved, the majority of engineered
PKSs have suboptimal activity, arising at least in part from
a lack of knowledge regarding precise domain boundaries
[5, 10, 11]. Further progress in the engineering of the bio-
synthesis of novel polyketides requires detailed insights
into the structure of DEBS and related modular PKSs.
We recently reported the 2.7 A˚ X-ray crystal structure of
a 194 kDa homodimeric [KS][AT] fragment of DEBS mod-
ule 5 [12]. In addition to the two pairs of catalytic KS and
AT domains and the N-terminal docking domain, the
structure also revealed two interdomain linker regions
with well-defined three-dimensional structures that each
show extensive interactions with the core catalytic do-
mains. Although the overall primary sequences of these
linker regions are less conserved compared to those of
the corresponding catalytic domains, the amino acid res-
idues responsible for specific domain-linker interactions
are highly conserved in all six DEBS modules.
Here, we present the 2.6 A˚ structure of a homologous
[KS][AT] fragment from DEBS module 3. In addition to1–943, August 2007 ª2007 Elsevier Ltd All rights reserved 931
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Structure and Mechanism of DEBSFigure 1. Modular Organization of 6-Deoxyerythronolide B Synthase Illustrating the Deduced Topology
6-Deoxyerythronolide B synthase (DEBS) contains three large homodimeric polypetides, each of which consists of twomodules. Eachmodule is min-
imally composed of a core set of ketosynthase (KS), acyltranferase (AT), and acyl carrier protein (ACP) domains. Additional ketoreductase (KR),
dehydratase (DH), and enoylreductase (ER) domains are responsible for processing of the b-ketoacyl-SACP intermediates, while a specialized
thioesterase (TE) domain releases the mature heptaketide chain with cyclization to generate the 6-deoxyerythonolide B product.reconfirming the major architectural features of previously
reported PKS modules and their constituent domains, the
structure, which includes a covalently bound molecule of
the inhibitor cerulenin, provides a clearer definition of the
KS active site. A detailed comparison between the active
sites of DEBS KS3 and KS5 reveals a set of residues that
are thought to control specificity for their respective trike-
tide and pentaketide substrates. Lastly, guided by the re-
cently solved NMR structure of the ACP domain of DEBS
module 2, we have proposed a plausible KS-ACP docking
model that predicts both electrostatic and hydrophobic
interactions at the critical domain-domain interface.
RESULTS AND DISCUSSION
Catalytic Activity of the Crystallized Fragment
of DEBS Module 3
Motivated by our earlier success with DEBS module 5, we
initially prepared and attempted to crystallize the full-length
[KS3][AT3] didomain protein with its intact N-terminal
docking domain as well as the KS-to-AT and post-AT
linkers. Unfortunately, no diffracting crystals could be ob-
tained from this recombinant protein. Guided by encour-
aging preliminary data for a 190 kDa proteolytic fragment
of this protein from which the N-terminal docking domain932 Chemistry & Biology 14, 931–943, August 2007 ª2007 Elshad been cleaved [13], we expressed the recombinant
protein corresponding to this trypsin fragment and purified
it to homogeneity. The KS acylation activity as well as the
chain-elongation properties of the purified protein were
assayed, so as to assess the catalytic consequences of
removing the N-terminal docking domain. Both activities
were preserved in this truncated form of module 3, albeit
at 30% of the activity of the intact [KS][AT] didomain
(data not shown). The recombinant truncated protein
was therefore used for initial crystallization screens, which
yielded needle crystals. Having established preliminary
crystallization conditions, the truncated protein was then
incubated with cerulenin, a known active-site-directed ir-
reversible inhibitor of the KS domains of numerous PKSs
and fatty acid synthases, and the protein-cerulenin adduct
was purified prior to protein crystallization. In a separate
set of experiments, the recombinant protein was also
incubated with (2S,3R)-2-methyl-3-hydroxypentanoyl-N-
acetylcysteamine thioester, and the resulting acylated
protein was purified for crystallization. Only the protein
incubated with cerulenin gave diffractable crystals.
Overall Structure
The cerulenin-inhibited form of the 190 kDa fragment of
DEBS module 3 was crystallized at room temperature byevier Ltd All rights reserved
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space group P21 with one homodimer per asymmetric
unit. The crystal structure was determined by molecular
replacement with the recently determined structure of
the [KS5][AT5] didomain from DEBS module 5 (PDB ID:
2HG4) as the search model. The structure was refined to
2.6 A˚ resolution, with R and Rfree values of 21.8% and
26.8%, respectively. The final protein model after refine-
ment contained 869 out of the 896 residues of the subunit;
no electron density was observed for 2 N-terminal resi-
dues, 14 C-terminal residues, and 11 residues from 2 in-
ternal disordered regions. In each monomer, the cerulenin
molecule was only partially defined by the electron den-
sity, suggesting that the octadienyl moiety of the inhibitor
that is distal to the point of attachment to the active site
cysteine is relatively flexible and therefore disordered in
the crystal. Data, refinement, and model statistics are
summarized in Table 1.
Notwithstanding the absence of the N-terminal docking
domain, the overall organization of the truncated
[KS3][AT3] didomain protein of DEBS module 3 is very
similar to that of the [KS5][AT5] protein fromDEBSmodule
5 (Figure 2). The homodimeric [KS3][AT3] protein has two
catalytic domains, KS3 and AT3, and two linker regions,
the KS-to-AT linker and the post-AT linker. The dimer in-
terface is located solely between the two KS domains.
Similar to other condensing enzymes from fatty acid syn-
thases and PKSs, each KS3 domain adopts the five-
layered ababa fold, first observed in thiolase [12, 14–18].
The dimer interface is primarily comprised of two antipar-
allel b strands, one from each subunit, that are held to-
gether by backbone hydrogen bonds, thereby creating
a ten-stranded b sheet. The salt bridges previously ob-
served at the KS5 dimer interface are not found in the cor-
responding KS3 dimer interface. Superposition of the Ca
atoms of the KS3 and KS5 domains gives an rmsd of
0.85 A˚ for 386 Ca atoms. A noticeable difference between
the KS3 and KS5 domain is that KS3 has a longer loop cor-
responding to residues 71–91. Sequence alignment
among the six DEBS KS domains shows that only KS5 is
12 residues shorter than other KS domains in this region,
indicating that the remaining KS domains will have
a loop of similar length to that of the KS3 domain.
The architecture of the AT3 domain is similar to that of
the Escherichia coli and the Streptomyces coelicolor ma-
lonyl-CoA:ACP transferases, as well as the DEBS AT5 do-
main [12, 19, 20]. The AT3 domain has an a,b-hydrolase
core and an appended smaller subdomain with a
ferredoxin-like structure. The structures of the DEBS
AT3 and AT5 domains can be superimposed with an
rmsd of 1.1 A˚ for 292 Ca atoms.
The 100 residue-long KS-to-AT linker of the
[KS3][AT3] protein is also structurally homologous to its
[KS5][AT5] counterpart, with only a 1.54 A˚ rmsd between
the backbone atoms of the two KS-to-AT linkers, in spite
of the fact that the overall sequence similarity (47%) be-
tween the two interdomain linkers is less than that
between the corresponding pairs of KS and AT catalytic
domains (60%). The KS3-to-AT3 linker contains aChemistry & Biology 14, 93three-stranded parallel b sheet, flanked by three a heli-
ces on one side and two a helices on the other. Similar
to the KS5-to-AT5 linker, the three a helices on one side
are part of the KS3-to-AT3 linker itself, while the two a he-
lices on the other side are contributed by the AT3 domain
and the post-AT linker, respectively. Finally, the post-AT
linker wraps around both the AT3 domain and the KS-to-
AT linker so as to engage in extensive contacts with the
KS3 domain. The previously observed, highly conserved
hydrophobic interactions between the two linkers and
the two catalytic domains of [KS5][AT5] are also observed
in the [KS3][AT3] protein. Specifically, the conserved res-
idues Phe102, Phe106, Phe107, Val109, Ala114, Leu125,
Trp129, Pro139, Met189, His516, Tyr898, and Phe900
comprise the hydrophobic core between the two linkers
and the KS3 domain, while Pro473, Val475, Leu507,
Table 1. Data Collection and Structure Refinement
Statistics
Data Collection Statistics
Wavelength (A˚) 0.979
Resolution (A˚) 2.60
Reflection (observed/
unique)
22,8717/62,083
Completeness (%) 99.8 (100)
Redundancy 3.7 (3.7)
I/s(I) 16.0 (3.1)
Rmerge
a 0.135 (0.688)
Refinement Statistics
Space group P21
Unit cell parameters a = 75.203 A˚, b = 139.005 A˚,
c = 102.342 A˚,
g = 106.14
Monomers per A.U. 2
Protein atoms 12,944
Water molecules 194
Rfree
b (%) 26.8
Rcrys
c (%) 21.8
Rms deviation
Bonds (A˚) 0.017
Angles () 1.94
Ramachandran plot (%)
Most favored 84.2
Additionally favored 13.4
Generously allowed 1.4
Disallowed 1.0
aRmerge = SjIo  <I>j/S<I> summed over all observations and
reflections.
b Rfree = Rcryst calculated for 5%of reflections omitted from the
refinement.
c Rcryst = SjFo  Fcj/SjFoj.1–943, August 2007 ª2007 Elsevier Ltd All rights reserved 933
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Structure and Mechanism of DEBSFigure 2. X-Ray Crystal Structure of the
[KS3][AT3] Didomain of DEBS Module 3
The protein forms a homodimer. The KS3 do-
main, the KS3-to-AT3 linker, the AT3 domain,
and the post-AT linker are shown in blue, yel-
low, green, and red, respectively. The con-
served hydrophobic cores at the domain-linker
interfaces of one monomer are shown as
colored spheres.Ala510, Ala521, Val548, Trp637, Tyr640, Phe867, Leu868,
Met871, Ala872, His875, Ile881, Trp883, and Leu887 form
the hydrophobic core between the two linkers and the AT3
domain (Figure 2).
In the [KS5][AT5] protein, the N-terminal docking do-
mains from the two monomers form an extended coiled-
coil structure, contributing to the homodimer interface
[12, 21]. The corresponding N-terminal residues involved
in the coiled-coil interface are well conserved in the native
DEBS module 3. It is therefore reasonable to expect that
the N-terminal docking domain in the full-length [KS3][AT3]
protein also forms a similar coiled-coil structure. In the
truncated [KS3][AT3] protein, the 4 residues, E27-L28-
E29-S30, at the N terminus belong to the original N-
terminal docking domain of DEBS module 3. While no
electron density was detected for the first two of these934 Chemistry & Biology 14, 931–943, August 2007 ª2007 Elseamino acids, the next 2 residues are visible in the
[KS3][AT3] structure. As shown in Figure 3A, Glu29-
Ser30-Asp31 at the N terminus of KS3 do not overlap
with the corresponding region of the [KS5][AT5] protein,
in which the intact coiled-coil N-terminal docking domain
is present (Figure 3A). Beyond this local difference, the ex-
cision of the N-terminal docking domain from KS3 has lit-
tle apparent effect on the overall KS3 dimer geometry.
Although the individual KS domain, KS-to-AT linker, and
AT domain structures are well conserved between the
[KS3][AT3] and [KS5][AT5] proteins, a significantly higher
net rmsd of 4.2 A˚ is observed when the entire structures
of both proteins are superimposed (Figure 3B). A close in-
spection of the superimposed structures shows that this
divergence stems from a rotation of 26 of the AT3 do-
main. As a result, the cleft between each AT3 domainFigure 3. Comparison of the Structures
of the [KS3][AT3] Didomain and the
[KS5][AT5] Didomain
(A) The coiled-coil N-terminal docking domain
of the [KS5][AT5] didomain (orange) is shown.
The residues E29–S30 at the N terminus of
[KS3][AT3] (blue) are shown in sticks. The dif-
ference in the region of the N-terminal docking
domains is depicted in the shadowed area.
(B) Superposition of the complete backbones
of the two didomains. The AT3 domain is ro-
tated 26 relative to the orientation of the
AT5 domain.
(C) Domain-domain interactions in the
[KS3][AT3] didomain. Asp555 forms a salt
bridge with Arg519; the latter residue is also
hydrogen bonded to His516 and H140.vier Ltd All rights reserved
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Structure and Mechanism of DEBSFigure 4. The Cerulenin-Binding Site in
the [KS3][AT3] Didomain
(A) The cerulenin molecule is covalently bound
to the enzyme; only the shaded portion is visi-
ble in the electron density map.
(B) Stereoview of the final 2Fo  Fc map at the
cerulenin (cyan)-binding site contoured at
1.0 A˚.
(C) Stereoview of the structure of the FabF-
cerulenin complex (magenta) superimposed
on the structure of the [KS3][AT3]-cerulenin
didomain (blue).and the KS3 dimer is smaller compared to its [KS5][AT5]
counterpart. The origin of this relatively ‘‘closed’’ confor-
mation of the [KS3][AT3] protein is unclear. It could be
a crystallization artifact due to crystal packing; alterna-
tively, the cleavage of the N-terminal docking domain
may contribute to this ‘‘closed’’ conformation, since this
truncated [KS3][AT3] only exhibits 30% of the activity of
the full-length protein. Nonetheless, this relatively
‘‘closed’’ conformation appears to be stabilized by a series
of specific interactions, including hydrogen bonding and
charge-charge interactions, that are absent in [KS5][AT5]
(Figure 3C). For example, Asp555 forms a hydrogen
bond with the side chain of Arg519, whose orientation is
fixed by hydrogen bonding to the backbone carbonyl ox-
ygens of both His516 and His875. In addition, Asp555 is
also engaged in charge-charge interactions with side
chains of both His140 and His516. Aside from Arg519
and His875, none of the residues involved in the above-
described interactions are conserved among the six
DEBS KS domains.
The Cerulenin-Binding Site in KS3
Analogous to other fatty acid synthase and polyketide
synthase condensing enzymes, the active site of the
KS3 domain is buried, and therefore only accessible byChemistry & Biology 14, 93the 18 A˚ phosphopantetheine arm of an ACP [12]. The ac-
tive site Cys202 residue of KS3 resides in a nucleophilic el-
bow in a tight turn between a b strand and an a helix.
His337 and His377, which form part of the catalytic triad,
are located adjacent to Cys202. Besides providing an oxy-
anion hole to promote nucleophilic attack on the carbonyl
of the acylthioester, these histidine residues have also
been implicated in catalyzing decarboxylation of the co-
substrate methylmalonyl-S-ACP [22, 23]. In the electron
density map of the [KS3][AT3]-cerulenin complex, only
the four-carbon hydrophilic head and attached groups of
the cerulenin adduct are visible, albeit with a higher B fac-
tor than the rest of the protein (Figures 4A and 4B). The
electron density corresponding to the hydrophobic octa-
dienyl tail of the inhibitor is missing, presumably because
of conformational disorder. A covalent bond is observed
between C-2 of the cerulenin adduct and the active site
Cys202. The carbonyl oxygen of the terminal carboxamide
hydrogen bonds with the NE atoms of His337 and His377,
while the carboxamide nitrogen is within hydrogen-
bonding distance of the backbone carbonyl oxygen of
Phe442 and a water molecule. No other contacts are ob-
served between the cerulenin adduct and the protein.
To date, two crystal structures of KS-cerulenin com-
plexes have been reported for b-ketoacyl-ACP:ACP1–943, August 2007 ª2007 Elsevier Ltd All rights reserved 935
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Structure and Mechanism of DEBSFigure 5. Substrate-Binding Models for the Active Sites of KS3 and KS5
(A) Model of the triketide-phosphopantetheine group in the KS3 active site showing proposed interactions with residues lining the substrate-binding
pocket.
(B) Model of the pentaketide-phosphopantetheine group in the KS5 active site showing proposed interactions with residues lining the substrate-
binding pocket.synthases of type II fatty acid synthases, FabB-cerulenin
and FabF-cerulenin [24, 25]. When the structure of
cerulenin-bound [KS3][AT3] is superimposed on that of
FabF-cerulenin, (Figure 4C), C-1 and C-2 of the covalently
attached inhibitor occupy almost identical positions in the
two proteins, while C-3 and C-4 are rotated more than
120 in the [KS3][AT3] complex relative to the FabF com-
plex. This rotation may reflect the conformation of the
flexible hydrophobic octadienyl tail of cerulenin in the
[KS3][AT3] active site, since cerulenin has a lower binding
affinity to KS domains from PKSs compared to those from
fatty acid synthases [26].
Substrate Specificity of the KS Domain:
Comparing DEBS KS3 to KS5
DEBS KS3 and KS5 share 60% sequence identity but
have different substrate specificities. The natural sub-
strate of KS3 is a triketide, whereas the natural substrate
of KS5 is a pentaketide (Figure 1). While KS3 can be stoi-
chiometrically acylated by the N-acetylcysteamine thio-
ester derivative of the natural diketide product of DEBS936 Chemistry & Biology 14, 931–943, August 2007 ª2007 Emodule 1, KS5 is acylated more slowly by this same ana-
log under the same conditions.
To better understand the structural basis for KS sub-
strate specificity, we docked the natural triketide sub-
strate of KS3, bound to a phosphopantetheinyl arm, into
the substrate-binding pocket of KS3. This simulated com-
plex was then superimposed onto the corresponding
KS5-pentaketide complex that had been modeled earlier
[12]. As shown in Figure 5, there are two major differences
between the substrate-binding pockets of the KS3 and
KS5 domains. First, a loop found at the dimer interface
in both proteins (residues 153–158 in KS3 and 149–154
in KS5) has substantially different conformations in the
otherwise very similar proteins. Compared to KS3, this
loop is more extended in KS5. This difference in loop con-
formation results in the side chains of 2 KS3 residues
(Lys155 and Phe156) being oriented in opposite directions
compared to the corresponding KS5 residues, Thr151 and
Val152. The orientation of Thr151 in KS5 is thought to be
important for binding of its pentaketide substrate, based
on a predicted hydrogen bond between the threoninelsevier Ltd All rights reserved
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The counterpart Lys155 residue in KS3 points away from
the substrate-binding site. In addition, KS3 has more
bulky residues in the active site than does KS5. For exam-
ple, Phe156, Val173, and Val237 in KS3, which presum-
ably interact with the untethered end of the polyketide
chain, correspond to the smaller Val152, Gly170, and
Ala234, respectively, in KS5. The resulting steric differ-
ences could influence the preferred substrate size that
can be accommodated in the two different active sites.
It must be noted, however, that neither substrate-
binding pocket is especially crowded and eachmay there-
fore readily undergo modest conformational adjustments
upon substrate binding. Indeed, such conformational flex-
ibility may be the origin of the observed relative substrate
promiscuity of modular PKSs [27].
Interaction between the [KS][AT] Homodimer
and an ACP Domain
During polyketide biosynthesis, the ACP domain interacts
with several catalytic sites, in each case serving as a scaf-
fold to which the malonyl- or methylmalonyl extender unit
and the growing polyketide chain are alternately tethered.
A number of recent studies have highlighted the critical
importance of KS:ACP specificity, both during intermodu-
lar chain transfer as well as during the intramodular KS-
catalyzed decarboxylative condensation reactions [28–
30]. Understanding the structural basis for this protein:-
protein specificity is of critical importance to the rational
engineering of catalytically efficient PKSs.
In addition to knowledge of the [KS3][AT3] structure,
computational prediction of the KS-ACP interface re-
quires an accurate molecular model for the cognate ACP
partner. Until recently, no structures were available for
ACP domains derived from modular PKSs. Although the
structures of more distantly related carrier proteins have
been solved [31–38], their level of sequence identity with
the DEBS ACP domains (<25%) is lower than the pairwise
sequence identities between DEBS ACP domains (45%–
55%).We have recently solved the solution NMR structure
of a recombinant ACP domain derived from DEBSmodule
2 and used this structure to derive homology models for
the six remaining DEBS ACP domains, including ACP3
[39]. We have now utilized the solution NMR structure of
ACP2 (the cognate partner of KS3 during intermodular
chain transfer) as well as the homology model of ACP3
(the cognate partner of KS3 during chain elongation) in
computational docking studies in order to gain insight
into the interface between the [KS3][AT3] protein and its
partner ACP2 and ACP3 domains.
The 3D-Dock [40] and Patchdock servers [41, 42] were
used for individual computational docking simulations be-
tween both the ACP2 and ACP3 domains and the
[KS3][AT3] protein. The two programs yielded similar
docking results for both ACPs. As shown in Figures 6A
and 6B, the most favorable ACP docking site, predicted
based on a combination of binding energy and shape
complementary, is the deep cleft between the KS3 and
AT3 domains. The orientations of ACP2 and ACP3 pre-Chemistry & Biology 14, 93dicted by the docking models are not identical; both the
N terminus and the C terminus of ACP3 are relatively
closer to the AT3 domain compared to ACP2. Nonethe-
less, the two docking models share important common
features. Notably, while the ACPs are docked in the cleft
of [KS3][AT3] subunit A, the active site residue Ser is actu-
ally positioned so as to direct its pantetheinyl prosthetic
group and attached substrate to the active site of the KS
domain of the paired subunit B. The validity of the calcu-
lated docking models is supported by three observations.
First, the Ser54 residues of both ACP2 and ACP3, to which
the 18 A˚ phosphopantetheinyl arms are covalently at-
tached, are predicted to be positioned near the entrance
of the substrate-binding pocket of one KS3 monomer B,
20 A˚ from the active site Cys202. Second, the docking
model predicts that each ACP domain will interact with
both subunits of the KS dimer. In a recently reported crys-
tal structure of the yeast fatty acid synthase, the ACP was
observed to preferentially bind to the KS domain, and to
interact with both subunits of the KS dimer, but functional
interaction was limited to one subunit of the KS dimer [43].
Although the overall architecture of the yeast fatty acid
synthase is distinct from modular PKSs such as DEBS, it
is likely that interaction between the core domain of yeast
ACP and the yeast KS domain is similar to that in modular
PKSs. Third, the crystal structure of the yeast FAS also re-
vealed that helix II of the core domain of ACP is important
for KS recognition [43]. In the ACP docking model, the
KS2-ACP2 and KS2-ACP3 interfaces both include helix
II of each ACP. For example, Arg61 of helix II of ACP3 is
predicted to form a hydrogen bond with Asn303 of KS3,
while Leu55 from helix II of ACP2 is involved in hydropho-
bic interactions with KS3.
One interesting question arises from the dockingmodel:
To which subunit of the homodimeric module does the
docked ACP3 belong? Previous mutant complementation
and crosslinking studies carried out in our lab have shown
that the ACP from one subunit preferentially interacts with
the KS domain from the opposite subunit [44]. In the ACP3
docking model, the C-terminal end of the post-AT linker
from [KS3][AT3] subunit A is indeed 16 A˚ closer to the
N terminus of the docked ACP3 domain than is the corre-
sponding C terminus of the post-AT linker belonging to
[KS3][AT3] subunit B. It is therefore tempting to conclude
that the illustrated ACP3 should belong to subunit A of the
homodimer (Figure 6B). This may be the case for those
PKS modules that consist only of the three core KS, AT,
and ACP domains, in which the location of the ACP is con-
strained only by the length of the AT-to-ACP linker. On the
other hand, since the native DEBS module 3 also harbors
an inactive KR domain (Figure 1), the position of the ACP
domain is restrained not only by the KR-to-ACP linker,
but also by the KR domain itself. Since, in the proposed
structure model for the full DEBS module 3 [45], it is not
yet possible to assign the individual KR domains to a given
subunit, it is therefore premature to try to assign the
docked ACP to a specific subunit of the homodimer pend-
ing the availability of an atomic resolution structure of the
entire module.1–943, August 2007 ª2007 Elsevier Ltd All rights reserved 937
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Structure and Mechanism of DEBSFigure 6. Calculated Docking Model for
the Interaction between ACP Domains
and the [KS3][AT3] Didomain
(A and B) The ACP domains are shown as violet
ribbons. The active site residues of the ACP
and KS domains are shown as spheres. The
[KS3][AT3] domain is shown in the same orien-
tation as in Figure 2. (A) Model of ACP2 docked
in the KS-AT cleft of the [KS3][AT3] didomain.
(B) Model of ACP3 docked in the KS-AT cleft
of the [KS3][AT3] didomain.An important feature of the ACP2 and ACP3 docking
models is that both ACP domains are predicted to interact
not only with both halves of the KS3 homodimer, but also
with a considerable portion of the remainder of the
[KS3][AT3] protein. In the discussion that follows, for brev-
ity only the ACP3 docking model is analyzed in detail.
A total of 1628 A˚2 surface area is predicted to be buried
upon ACP3 binding, while the surface area buried be-
tween the KS3 homodimer and ACP3 is only 983 A˚2. In
fact, in a companion study carried out in our lab, we
have shown that the efficiency of recognition of ACP3 by
the KS3 domain is greatly enhanced by the presence of
both the AT3 domain and the post-AT linker [46]. The inter-
actions predicted to occur at the [KS3][AT3]-ACP3 inter-
face are due to the contacts between ACP3 and the KS3
homodimer and the contacts between ACP3 and the
rest of the [KS3][AT3] protein.
The interface between ACP3 and the KS3 homodimer
involves both hydrophobic and hydrophilic interactions.938 Chemistry & Biology 14, 931–943, August 2007 ª2007 ElsevFor example, Phe78 of the ACP3 is predicted to bind in
a hydrophobic KS3 core region (Figure 7). As illustrated
by the multiple sequence alignment (Figure S1; see the
Supplemental Data available with this article online),
Phe78 of ACP3 is in fact strictly conserved in type I
PKSs, but not in type II PKSs. The same is true for the de-
duced hydrophobic cores in the corresponding type I KS
domains or type II proteins (sequences not shown). In
the NMR solution structure of ACP2 and the homology
model of ACP3, Phe78 is located on the protein surface,
with its side chain pointing away from the protein. Interest-
ingly, in the carrier protein domains (thiolation or T do-
mains) of the enterobactin nonribosomal peptide synthe-
tase, the residues that align with Phe78 of ACP3 have
been shown to play key roles in mediating protein-protein
interactions [47, 48]. In the latter system, mutation of
Ala268 to Gln in the EntB-ArCP degraded interaction
with EntF, leading to a 90-fold reduction in the rate of en-
terobactin production [47]. In a like manner, mutation ofier Ltd All rights reserved
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Structure and Mechanism of DEBSFigure 7. Close-Up View of the ACP3
Docking Model
The residues involved in ACP-KS and ACP-AT
charge-charge interactions are shown as
sticks, and the KS and KS-to-AT linker resi-
dues involved in hydrophobic interactions
with ACP3 are shown as gray and yellow, re-
spectively, spheres.the corresponding residue in the EntF-T domain abolished
transfer of the acetyl group from the T to the thioesterase
(TE) domain, indicating the crucial role of this residue in
T-TE interaction [48]. Together, those observations rein-
force the idea that Phe78 of ACP3 may be important for
protein-protein interactions in DEBS KS3.
To directly investigate the role of Phe78 of the ACP3 do-
main, this residue was mutated to a charged Asp residue
in order to disrupt the proposed hydrophobic interactions
with the conserved hydrophobic core of the [KS][AT] dido-
main. Circular dichroism (CD) analysis confirmed the
structural integrity of the F78D mutant relative to the
wild-type ACP3 (Figure S2). The steady-state kinetic
parameters were determined for the F78D mutant by
assaying the conversion of the diketide substrate,
(2S,3R)-2-methyl-3-hydroxypentanoyl-N-acetylcysteamine
thioester, to the corresponding triketide ketolactone cata-
lyzed by [KS3][AT3] [30]. The [KS3][AT3] protein was first
incubated with the diketide to effect acylation, and then
[14C]methylmalonyl-CoA and ACP3 (WT or F78D) were
added to the mixture. After incubation for an appropriate
amount of time, the reaction was quenched and the de-
rived triketide ketolactone was quantified (Figure S3 and
Table S1). Mutation of F78D resulted in a modest de-
crease in efficiency of triketide lactone formation, as re-
flected in a 2-fold decrease in kcat as well as a 2-fold in-
crease in KM, resulting in a net 4-fold reduction in
catalytic efficiency (kcat/KM) relative to the wild-type
ACP3. These results suggest that Phe78 may contribute,
but is not critical for, to the interaction between ACP3
and [KS3][AT3].
The hydrophilic interactions at the KS3-ACP3 interface
involve several charged residues. In addition to the hydro-
gen bond between Arg61 of ACP3 and Asn303 of KS3,Chemistry & Biology 14, 93Asp53 and Asp79 of ACP3 are likely involved in charge-
charge interactions with Arg184 and Arg143 of KS3, re-
spectively; these 4 residues are strictly conserved in all
DEBS modules. Additional charge-charge interactions
are predicted between Arg71 of ACP3 and Asp354 and
Asp413 of KS3. None of these residues are conserved
among other DEBS modules, suggesting that this electro-
static interaction may contribute to the observed KS:ACP
recognition specificity [30].
The interaction at the interface of ACP3 and AT3 in the
ACP3 docking model involves Arg44 of ACP3 and
Glu849 and Asp850 of AT3. None of these 3 residues
are conserved in the remaining five DEBS modules, sug-
gesting that these charge-charge interactions may also
contribute to the KS3:ACP3 specificity [30]. Since it is
has been shown that KS3 and KS6 have orthogonal spec-
ificities toward ACP3 and ACP6, we wanted to test
whether mutations around Arg44 of ACP3 could change
the KS:ACP recognition specificity. Arg44 and Arg45 of
ACP3 were therefore mutated to Asp and Gln, respec-
tively, corresponding to the homologous residues of
ACP6. Two single mutants—R44D, R45Q—and one
double mutant—R44D/R45Q—were constructed. The
CD spectra of the mutants showed characteristics of an
a-helical conformation, suggesting equivalent tertiary
structures of the mutants and wild-type ACP3 (Fig-
ure S2). The polyketide chain-elongation assay was
carried out by using [KS3][AT3] or [KS6][AT6] in combina-
tion with these three mutants. As shown in Figure S4, the
two single mutants behaved similarly to the wild-type.
Thus, no triketide ketolactone formation was observed
when the two single ACP3 mutants were incubated with
[KS6][AT6]. In contrast, the double mutant totally lost the
ability of the wild-type to interact productively with1–943, August 2007 ª2007 Elsevier Ltd All rights reserved 939
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wild-type ACP6. Taken together, the results of these ex-
periments strongly suggest that specific hydrophilic inter-
actions between ACP3 and KS3 involving Arg44 and
Arg45 of ACP3 contribute to the observed KS3:ACP3 rec-
ognition specificity.
It should be stressed that functional interaction between
ACP3 and the active site of the AT3 domain, from which
the pantetheinyl group of ACPmust acquire its methylma-
lonyl residue, cannot take place when ACP3 is bound as
predicted into the cleft between the KS3 and AT3 do-
mains. Similar to the [KS5][AT5] homodimer, the respec-
tive active site Cys and Ser residues of the KS3 and AT3
domains are separated by 76 A˚. A second, functionally
distinct, ACP3-AT3 docking sitemust therefore be present
on the face of the AT domain distal to the KS3-AT3 cleft.
The latter interaction was not revealed, however, by the
docking simulations.
SIGNIFICANCE
Modular PKSs are responsible for the biosynthesis of
polyketide natural products with a variety of antibiotic,
antiviral, immunosuppressant, cholesterol-lowering,
and anticancer activities. The modular organization
of these PKSs makes them attractive targets for engi-
neering designed to allow for combinatorial biosyn-
thesis of novel polyketide metabolites. Until now,
however, the lack of detailed structural andmechanis-
tic information for these megaenyzmes has greatly
hampered progress in rational engineering of these
modular polyketides, with primary sequence align-
ments being the only effective tool for predicting the
boundaries of the constituent functional domains.
The crystal structure of a 190 kDa homodimeric dido-
main fragment of DEBS module 3 with a covalently
bound cerulenin at the KS3 active site provides impor-
tant new, to our knowledge, insights into the structure
and function of modular PKS proteins. The bound cer-
ulenin also provides a more refined definition of both
the KS3 and KS5 active sites. Detailed structural com-
parison between the structures of DEBS KS3 and KS5
highlight specific residues that may be important in
determining both intrinsic substrate specificity and
tolerance of the KS domains. Docking simulation
with both the ACP2 NMR solution structure and an
ACP3 homology model predicts that the ACP domain
interacts with the KS domain by binding in the deep
cleft between the KS and AT domains. Our results
open the door to future efforts to engineer useful poly-
ketide products with important medicinal activities.
EXPERIMENTAL PROCEDURES
Reagents and Chemicals
DL-[2-methyl-14C]-methylmalonyl-CoA was purchased from American
Radiolabeled Chemicals. (2S,3R)-2-methyl-3-hydroxypentanoyl-N-
acetylcysteamine thioester was prepared by established methods
[49–51]. All other chemicals were purchased from Sigma. Thin-layer
chromatography (TLC) plates were a gift from J.T. Baker. SDS940 Chemistry & Biology 14, 931–943, August 2007 ª2007 ElsePAGE-gradient gels (4%–15% acrylamide) were purchased from Bio-
Rad. Ni-NTA affinity resin was purchased from QIAGEN. HiTrap-Q an-
ion-exchange column was purchased from Amersham Pharmacia.
Cloning, Expression, and Purification of the [KS3][AT3]
Didomain of DEBS Module 3
The construction of an expression vector encoding the [KS3][AT3] di-
domain from DEBSmodule 3 (pAYC02) has been previously described
[30]. The N-terminal KS linker was deleted from the [KS3][AT3] dido-
main, by using PCR to amplify pAYC02 from ELES to the natural
AscI site, and an engineered NdeI site was introduced with primers
50-GCAGCGCCATATGGAGCTGGAATCCGACCCGATCG-30 and 50-
GCGGCGCGCCGAGTCCGCTCGCC-30. The resulting NdeI-AscI
fragment was cloned back into NdeI-AscI-digested pAYC02 to yield
plasmid pAYC09, encoding the DEBS [KS3][AT3] didomain lacking
the N-terminal docking domain. The sequence of pAYC09 was verified
directly by DNA sequencing, and the plasmid was introduced into
E. coli BL21(DE3) cells by electroporation. The resulting transformant
was grown in LB medium at 37C to an OD600 of 0.6. The culture
was then cooled to 18C, followed by induction with 0.2 mM isopropyl-
b-D-thiogalactopyranoside, and was grown for an additional 14 hr at
18C. The cells were harvested by centrifugation (44203 g for 15 min),
resuspended in lysis/wash buffer (50 mM phosphate [pH 7.6], 300 mM
NaCl, 10 mM imidazole), and lysed by sonication (53 1 min). After the
cell debris was removed, the supernatant was applied to a Nickel-NTA
agarose (QIAGEN) column in batch mode. After extensive washing
with 10 column volumes of lysis/wash buffer, the protein was eluted
with 3 column volumes of elution buffer (50 mM phosphate [pH 7.6],
100 mM NaCl, 150 mM imidazole). After determination of the protein
concentration by using a Biorad assay, a 100molar excess of the inhib-
itor cerulenin was added, and the mixture was allowed to incubate
overnight at 4C to effect covalent modification. The resulting modified
protein was further polished on a Hi-Trap-Q anion-exchange column
(Amersham-Pharmacia) by using a linear gradient of NaCl, with elution
of the protein-inhibitor complex at 350 mM NaCl. The purified com-
plex was exchanged into 20 mM HEPES buffer (pH 7.6) and was
concentrated to 1 mg/ml. The typical yield of the KS-AT didomain-
cerulenin complex was 20 mg/l culture.
Crystallization and Data Collection for the [KS3][AT3]
Didomain of DEBS Module 3 Complexed with Cerulenin
Crystals were grown at room temperature by using the hanging-drop
vapor-diffusion method with a ratio of 2 ml [KS3][AT3]-cerulenin com-
plex solution (1 mg/ml) to 2 ml mother liquor. The well buffer contained
0.1 M HEPES (pH 7.0), 0.2 M Li2SO4, and 25% PEG 3350. The crystals
belong to space group P21 and contain two monomers per symmetric
unit. The unit cell has dimensions of a = 75.203 A˚, b = 139.005 A˚, c =
102.342 A˚, b = 106.14. For cryocooling, the crystals were harvested
in a well solution with 10% glycerol. Diffraction data sets were col-
lected on beamline 11-1 at the Stanford Synchrotron Radiation Labo-
ratory (SSRL) to 2.6 A˚ and were processed with the HKL2000 package
[52]. The crystallographic data are summarized in Table 1.
The [KS3][AT3] protein acylated with (2S,3R)-2-methyl-3-hydroxy-
pentanoyl-N-acetylcysteamine thioester was also used in crystalliza-
tion, but no diffractable crystals were obtained.
Structure Refinement and Model Building
Initial phases were obtained by molecular replacement by using the
programMolrep in CCP4i [53] and the coordinates of the DEBSmodule
5 [KS5][AT5] didomain (PDB ID: 2HG4) as the search model. The se-
quence was replaced by that of the [KS3][AT3] didomain from DEBS
module 3, and the structure was further refined by using CCP4i and
was then fit manually with O [54] and Coot [55]. Noncrystallographic
symmetry restraints were applied for the initial rounds of refinement
and were removed for final stages. Both the 2Fo  Fc and Fo  Fc
maps showed the presence of a portion of the bound cerulenin in
the active site of the KS3 domain. The three-dimensional structure of
the relevant portions of the cerulenin adduct was then fit by hand
into the visible electron density. Both sites in the asymmetric unitvier Ltd All rights reserved
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cules. Water molecules were added by using Coot, followed by visual
inspection with O at the final stage. A total of 5% of the reflections were
excluded from refinement and constituted the Rfree set. The final ge-
ometry was assessed with PROCHECK [56].
Molecular Docking Simulations
The homology model of the DEBS ACP3 domain was generated by us-
ing the WHATIF homology model server [57] based on the solution
NMR structure of the DEBS ACP2 domain (PDB ID: 2JU2) [38]. The cal-
culated docking between ACP3 and the [KS3][AT3] didomain was car-
ried out by using both the 3D-Dock program suite [40] and the Patch-
dock server [41, 42] (http://bioinfo3d.cs.tau.ac.il/PatchDock/index.
html). When the 3D-Dock program suite was used, the coordinates
of the dimeric [KS3][AT3] didomain were defined as the static model,
with ACP3 defined as the mobile model. The binding interface was ex-
haustively searched by using default parameters. The resulting com-
plexes were then scored by an empirical pair potential matrix [58],
and the best-scored complex was energy minimized by CCP4i [53].
When the Patchdock server was used, the dimeric [KS3][AT3] dido-
main was defined as the receptor and the ACP3 protein was defined
as the ligand. The best-docking models returned by both programs
were very similar, and each identified the deep cleft between the KS
domain and the AT domain as the ACP3 docking site. The specific
model that is discussed in detail in the text was calculated by using
the Patchdock server. The docking between ACP2 and the
[KS3][AT3] didomain was carried out in a similar manner.
Construction, Expression, and Purification of ACP3 Mutants
F78D, R44D, R45Q, R44D/R45Q
Mutagenesis was performedwith theQuikChange Site-DirectedMuta-
genesis Kit (Stratagene). Primers 50-TCGCTGGTGGACGACCACCCC
ACCG-30, 50-CGCCGAGATCAACGTGGACCGCGCGTTCAGCG-30,
50-CGAGATCAACGTGCGCCAGGCGTTCAGCGAGCTCG-30, and 50-
CGCCGAGATCAACGTGGACCAGGCGTTCAGCGAGCTCG-30 and
their complementary oligonucleotides were used to introduce the
F78D, R44D, R45Q, and R44D/R45Q mutation(s), respectively, into
DEBS ACP3. The expression and purification of the mutants were car-
ried as described for wild-type ACP3 [13, 30].
Triketide Ketolactone Formation
[KS3][AT3] idomain (2 mM for the F78D mutant time course and 10 mM
for experiments with the R44D, R45Q, and R44D/R45Q mutants, in
100 mM phosphate [pH 7.2]) was incubated with 5 mM (2S,3R)-2-
methyl-3-hydroxypentanoyl-N-acetylcysteamine thioester and 5 mM
TCEP for 1 hr at room temperature to acylate KS3 to completion. Holo
ACP (four ACP concentrations ranging from 2 to 200 mM) and 200 mM
DL-[2-methyl-14C]methylmalonyl-CoA were then added and allowed
to react at room temperature. At various time points, 10 ml reaction so-
lution was drawn from the reaction mixture and quenched by adding
20 ml 0.5 M potassium hydroxide. The mixture was further processed
as described previously [30].
Circular Dichroism Spectroscopy
The proteins were diluted in 20 mM potassium phosphate (pH 7.2). All
of the proteins had a concentration of 0.25 mg/ml; circular dichroism
ellipticity was recorded with an Aviv 202-01 instrument (Aviv Associ-
ates, Lakewood, NJ). Spectra from 270 to 190 nm were scanned at
a step of 1 nm at 25C in a 0.1 cm cuvette, with three repeats and
an averaging time of 1 s.
Supplemental Data
Supplemental Data include Figures S1–S4 and Tables S1 and S2
and are available at http://www.chembiol.com/cgi/content/full/14/8/
931/DC1/.
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